SK Plasma Co., Ltd. clinical trials

Formerly part of SK Chemicals Co., Ltd.

The registry lists 4 studies whose lead sponsor is SK Plasma Co., Ltd.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 18, 2024.

Status

Completed: 2
Not yet recruiting: 1
Terminated: 1

Phase

Phase 3: 3
Phase 2: 1

Where

Korea, Republic of: 3

Registry sponsor names on this page

SK Plasma Co., Ltd.4 studies

Something wrong with this grouping? Tell us on the SK Chemicals Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 4 of 4. All SK Chemicals Co., Ltd. studies →

An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a PatientsNot yet recruitingNCT06738901Phase 3
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver TransplantationTerminatedNCT05666453Phase 2
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)CompletedNCT05566990Phase 3
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)CompletedNCT03164915Phase 3
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.